Cartesian Therapeutics | 8-K:重大事件
Cartesian Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-FMR LLC(3.925%),Abigail P. Johnson(3.925%)
Cartesian Therapeutics | 10-Q:季度报表
Cartesian Therapeutics | 8-K:Cartesian Therapeutics公布2024年第一季度财务业绩并提供业务最新情况
Cartesian Therapeutics | DEF 14A:股东委托书决议
Cartesian Therapeutics | DEFA14A:其他
Cartesian Therapeutics | 8-K:重大事件
Cartesian Therapeutics | 3:首次持股声明-高管 English Emily
Cartesian Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-Timothy A. Springer(36.4%),TAS Partners LLC(11.8%)等
Cartesian Therapeutics | 4:持股变动声明-董事 Singer Michael
Cartesian Therapeutics | 4:持股变动声明-董事 Kalayoglu Murat
Cartesian Therapeutics | 4:持股变动声明-董事 SPRINGER TIMOTHY A
Cartesian Therapeutics | 4:持股变动声明-高管 Jewell Christopher M
Cartesian Therapeutics | 4:持股变动声明-高管 Miljkovic Milos
Cartesian Therapeutics | 4:持股变动声明-高管 Kurtoglu Metin
Cartesian Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-Murat Kalayoglu(19.9%),Seven One Eight Three Four Irrevocable Trust(17.1%)等
Cartesian Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-Michael Singer(4.3%),Baharak Asefzadeh(2.6%)等
Cartesian Therapeutics | 4:持股变动声明-股东 Hoge Elizabeth
Cartesian Therapeutics | 8-K:重大事件
Cartesian Therapeutics | 8-K:重大事件
暂无数据